amifostine anhydrous has been researched along with Intestinal Diseases in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Chen, Q | 1 |
| Wu, S | 1 |
| Xia, X | 1 |
| Wu, A | 1 |
| Cui, F | 1 |
| Gu, YP | 1 |
| Zhang, X | 1 |
| Cao, J | 1 |
1 other study available for amifostine anhydrous and Intestinal Diseases
| Article | Year |
|---|---|
Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
Topics: Amifostine; Animals; Bone Marrow Diseases; Drug Synergism; Intestinal Diseases; Male; Mice; Mice, In | 2015 |